Abstract
Botulinum toxin (BoNT), a potent neurotoxin that reversibly blocks presynaptic acetylcholine release, has been used successfully to treat sleep bruxism (SB) and chronic migraine (CM). However, studies investigating injection protocols such as drug dosage and injection site in the temporal muscle (TM) have rarely been reviewed. Therefore, recent studies involving the application of BoNT to the TM in patients with SB and CM was reviewed in this study.
Funder
Ministry of Science and ICT
Ministry of Trade, Industry and Energy
Ministry of Health and Welfare
Ministry of Food and Drug Safety
Korea Medical Device Development Fund
Publisher
Korean Society of Sleep Medicine
Subject
Physiology (medical),Psychiatry and Mental health,Neurology (clinical),Neurology,Pulmonary and Respiratory Medicine